Geraldo Bezerra da Silva Junior1,2, Juliana Gomes Ramalho de Oliveira1, Marcel Rodrigo Barros de Oliveira3, Luiza Jane Eyre de Souza Vieira1, Eduardo Rocha Dias4. 1. Postgraduate Program in Collective Health, Health Sciences Center, University of Fortaleza. Fortaleza (CE), Brasil. 2. Department of Epidemiology and Prevention of Renal Disease, Brazilian Society of Nephrology. São Paulo (SP), Brasil. 3. Nephrology Service, General Hospital of Fortaleza. Fortaleza (CE), Brasil. 4. Postgraduate Program in Constitutional Law, Center for Legal Sciences, University of Fortaleza. Fortaleza (CE), Brasil.
Abstract
OBJECTIVE: The aim of this study is to discuss the global costs attributed to chronic kidney disease (CKD) and its impact on healthcare systems of developing countries, such as Brazil. METHODS: This is a systematic review based on data from PubMed/Medline, using the key words "costs" and "chronic kidney disease", in January 2017. The search was also done in other databases, such as Scielo and Google Scholar, aiming to identify regional studies related to this subject, published in journal not indexed in PubMed. Only papers published from 2012 on were included. Studies on CKD costs and treatment modalities were prioritized. The search resulted in 392 articles, from which 291 were excluded because they were related to other aspects of CKD. From the 101 remaining articles, we have excluded the reviews, comments and study protocols. A total of 37 articles were included, all focusing on global costs related to CKD. RESULTS: Despite methods and analysis were diverse, the results of these studies were unanimous in alerting for the impact (financial and social) of CKD on health systems (public and private) and also on family and society. CONCLUSIONS: To massively invest in prevention and measures to slow CKD progression into its end-stages and, then, avoid the requirement for dialysis and transplant, can represent a huge, and not yet calculated, economy for patients and health systems all over the world.
OBJECTIVE: The aim of this study is to discuss the global costs attributed to chronic kidney disease (CKD) and its impact on healthcare systems of developing countries, such as Brazil. METHODS: This is a systematic review based on data from PubMed/Medline, using the key words "costs" and "chronic kidney disease", in January 2017. The search was also done in other databases, such as Scielo and Google Scholar, aiming to identify regional studies related to this subject, published in journal not indexed in PubMed. Only papers published from 2012 on were included. Studies on CKD costs and treatment modalities were prioritized. The search resulted in 392 articles, from which 291 were excluded because they were related to other aspects of CKD. From the 101 remaining articles, we have excluded the reviews, comments and study protocols. A total of 37 articles were included, all focusing on global costs related to CKD. RESULTS: Despite methods and analysis were diverse, the results of these studies were unanimous in alerting for the impact (financial and social) of CKD on health systems (public and private) and also on family and society. CONCLUSIONS: To massively invest in prevention and measures to slow CKD progression into its end-stages and, then, avoid the requirement for dialysis and transplant, can represent a huge, and not yet calculated, economy for patients and health systems all over the world.
Authors: Paul Kairys; Thomas Frese; Paul Voigt; Johannes Horn; Matthias Girndt; Rafael Mikolajczyk Journal: PLoS One Date: 2022-01-05 Impact factor: 3.240
Authors: David K E Lim; James H Boyd; Elizabeth Thomas; Aron Chakera; Sawitchaya Tippaya; Ashley Irish; Justin Manuel; Kim Betts; Suzanne Robinson Journal: PLoS One Date: 2022-07-26 Impact factor: 3.752
Authors: David Lim; Sean Randall; Suzanne Robinson; Elizabeth Thomas; James Williamson; Aron Chakera; Kathryn Napier; Carola Schwan; Justin Manuel; Kim Betts; Chris Kane; James Boyd Journal: Appl Clin Inform Date: 2022-09-28 Impact factor: 2.762